News related to Nutropin AQ (Human Growth Hormone) and/or conditions it is approved for
Clinical Data Show Long Acting Human Growth Hormone ARX201 Is Safe And Well Tolerated
Source: Endocrinology News From Medical News Today [2008.11.14]
Ambrx Inc. announced Phase I/II clinical trial data demonstrating that ARX201, the company's long-acting human growth hormone (hGH) analogue developed in collaboration with Merck Serono, normalized insulin-like growth factor I (IGF-I) levels while delivering an acceptable safety and tolerability profile in adults with Growth Hormone deficiency.
Is Human Growth Hormone a Key to Longevity?
Source: MedicineNet Hormone Therapy Specialty [2008.10.13]
Title: Is Human Growth Hormone a Key to Longevity?
Category: Health News
Created: 10/11/2008 2:00:00 AM
Last Editorial Review: 10/13/2008
Human Growth Hormone Doesn't Improve Athletic Performance
Source: MedicineNet Edema Specialty [2008.03.18]
Title: Human Growth Hormone Doesn't Improve Athletic Performance
Category: Health News
Created: 3/18/2008 2:00:00 AM
Last Editorial Review: 3/18/2008
Human Growth Hormone (hGH): Is it safe?
Source: MedicineNet Steroid Withdrawal Specialty [2007.02.06]
Title: Human Growth Hormone (hGH): Is it safe?
Category: Ask The Experts
Created: 2/6/2007
Last Editorial Review: 2/6/2007
|
